Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2023-10-20 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement released via RNS (Regulatory News Service) from Genedrive plc, dated October 20, 2023. The core content announces an 'Application for Listing' of new ordinary shares (3,240,000 New Ordinary Shares) related to an Equity Prepayment facility drawdown. It explicitly states the expected admission date and confirms the new total voting rights figure for shareholders. This action—the issuance of new shares and subsequent admission to trading—falls under capital structure changes or share issuance. While it relates to shares, the primary action is the announcement of the admission of new shares, which aligns closely with 'Share Issue/Capital Change' (SHA). However, the document is a short, formal regulatory notification distributed via RNS, and the content is a specific corporate action announcement (share admission/voting rights update) that is not a full financial report or a general proxy statement. Given the context of RNS distribution and the nature of the announcement (share issuance/voting rights update), SHA is highly relevant. Since the document is short and is a direct regulatory update, it could also be considered RNS, but SHA is more specific to the content. I will classify it as SHA as it details the issuance and resulting total share count, which is a capital change event.
2023-10-20 English
c£1.2m grant awarded
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and contains a date (28 September 2023) and company information (Genedrive PLC). The content is a brief update regarding a grant award and its implications for product validation, which is typical of a regulatory news service announcement. It is not a full financial report (10-K, IR), a transcript (CT), or a detailed presentation (IP). Since it is a general regulatory announcement distributed via RNS, and it doesn't fit neatly into the other specific categories like Director's Dealing (DIRS) or Dividend Notice (DIV), the most appropriate classification is the general regulatory filing category.
2023-09-28 English
Application for listing & total voting rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the RNS Number header and explicitly states it is providing information via RNS, the news service of the London Stock Exchange. The content announces an 'Application for Listing' of new ordinary shares related to a financing facility drawdown. This action—the issuance of new shares and the resulting change in total voting rights—falls under capital structure changes or share issuance. While it relates to financing (CAP), the primary action described is the admission of new shares and the notification of the resulting total share count, which is a specific type of capital change announcement. Given the options, 'Share Issue/Capital Change' (SHA) is the most precise fit for announcing the admission of new shares and updating the total voting rights denominator. It is not a general regulatory filing (RNS) because it fits SHA better, nor is it a financing update (CAP) which usually details the terms of the facility itself, rather than the resulting share admission.
2023-09-21 English
Board changes
Board/Management Information Classification · 1% confidence The document is an official announcement disseminated via RNS (Regulatory News Service) on September 11, 2023. The primary content explicitly announces 'Board changes,' specifically the appointment of a new CEO (James Cheek) and an Executive Director (Dr Gino Miele), and the stepping down of the previous CEO. This directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is not general regulatory news but a specific management change, making MANG the most precise classification.
2023-09-11 English
UKCA marking achieved for new CYP2C19 test
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated September 6, 2023. It announces a specific operational achievement: achieving UKCA marking for a new diagnostic test (Genedrive® CYP2C19 System) and outlines the next steps for commercialization and regulatory submissions (CE marking). This type of announcement, which is a specific, timely update on a company event or product status, is characteristic of a general regulatory news service release. The presence of the RNS header and the concluding boilerplate text confirming RNS as the information provider strongly suggests this is a regulatory filing that doesn't fit the more specific categories like 10-K, ER, or DIV. Since it is a general regulatory announcement, the most appropriate fallback category is RNS.
2023-09-06 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the header 'RNS Number : 4022I' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces an application for the Admission to trading of new Ordinary Shares related to an Equity Prepayment facility and confirms the Total Voting Rights figure. This is a standard regulatory announcement made via the RNS system. Since it is a general regulatory announcement that doesn't fit perfectly into specific categories like Share Issue (SHA) or Capital Financing (CAP), and it is clearly an RNS release, the most appropriate classification is the general regulatory filing category.
2023-08-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.